Elutia, Inc. (ELUT)
0.8198
-0.01
(-1.23%)
USD |
NASDAQ |
Sep 25, 16:00
0.81
-0.01
(-1.20%)
After-Hours: 19:59
Elutia Price to Book Value : 2.306 for Sept. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 2.306 |
| September 24, 2026 | 2.334 |
| September 23, 2026 | 2.442 |
| September 22, 2026 | 2.279 |
| September 21, 2026 | 2.400 |
| September 18, 2026 | 2.391 |
| September 17, 2026 | 2.391 |
| September 16, 2026 | 2.278 |
| September 15, 2026 | 2.250 |
| September 14, 2026 | 2.208 |
| September 11, 2026 | 2.278 |
| September 10, 2026 | 2.251 |
| September 09, 2026 | 2.250 |
| September 08, 2026 | 2.334 |
| September 04, 2026 | 2.310 |
| September 03, 2026 | 2.363 |
| September 02, 2026 | 2.378 |
| September 01, 2026 | 2.422 |
| August 31, 2026 | 2.430 |
| August 28, 2026 | 2.475 |
| August 27, 2026 | 2.475 |
| August 26, 2026 | 2.813 |
| August 25, 2026 | 2.841 |
| August 24, 2026 | 2.686 |
| August 21, 2026 | 2.675 |
| Date | Value |
|---|---|
| August 20, 2026 | 2.536 |
| August 19, 2026 | 2.597 |
| August 18, 2026 | 2.560 |
| August 17, 2026 | 2.745 |
| August 14, 2026 | 2.647 |
| August 13, 2026 | 2.420 |
| August 12, 2026 | 2.301 |
| August 11, 2026 | 2.254 |
| August 10, 2026 | 2.290 |
| August 07, 2026 | 2.391 |
| August 06, 2026 | 2.478 |
| August 05, 2026 | 2.453 |
| August 04, 2026 | 2.453 |
| August 03, 2026 | 2.438 |
| July 31, 2026 | 2.410 |
| July 30, 2026 | 2.546 |
| July 29, 2026 | 2.475 |
| July 28, 2026 | 2.574 |
| July 27, 2026 | 2.701 |
| July 24, 2026 | 2.616 |
| July 23, 2026 | 2.623 |
| July 22, 2026 | 2.621 |
| July 21, 2026 | 2.672 |
| July 20, 2026 | 2.616 |
| July 17, 2026 | 2.672 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 19.18 |
| Anika Therapeutics, Inc. | 1.986 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.570 |
Price to Book Value Related Metrics
| PS Ratio | 2.988 |
| Price | 0.8198 |
| Earnings Yield | -82.42% |
| Market Cap | 36.31M |